Now that the shortage of semaglutide injection products has been resolved, the Food and Drug Administration (FDA) will restrict third parties ...
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...
After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...
On February 21, 2025, the US Food and Drug Administration (FDA) revised its shortage categorization of semaglutide, a glucagon-like peptide 1 ...
A federal court in Texas has rejected a request by producers of compounded drugs to extend their ability to manufacture ...
The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, which both contain the active ingredient semaglutide and are approved ...
The online company advertised its sale of compounded GLP-1 drugs in a 60-second Super Bowl ad earlier ... provide compounded semaglutide to the extent it is able. “We do compound semaglutide.
Novo Nordisk is taking a page out of Eli Lilly’s playbook as the two GLP-1 drugmakers work to fend off compounding pharmacies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback